ARTERIAL HYPERTENSION IN SYSTEMIC VASCULITIS: CLINICAL FEATURES AND PRINCIPLES OF PATHOGENETIC THERAPY. PART I. CLINICAL, DIAGNOSTIC AND PATHOGENETIC ASPECTS
https://doi.org/10.20996/1819-6446-2013-9-5-557-563
Abstract
The article deals with the problem of arterial hypertension in systemic vasculitis. Data on the epidemiology, pathogenesis, and clinical aspects of hypertension in systemic vasculitis are presented.
About the Authors
E. A. Praskurnichy
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation
Russian Federation
N. G. Poteshkina
Russian National Research Medical University named after N.I., Moscow
Russian Federation
Russian Federation
References
1. Nasonov EL, Baranov AA, Shilkina NP. Vasculitis and vasculopathy. Yaroslavl: Verhnia Volga: 1999. Russian (Насонов Е.Л., Баранов А.А., Шилкина Н.П. Васкулиты и васкулопатии. Ярославль: Верхняя Волга: 1999).
2. Baranov AA Recommendations for the management of patients vasculitis (based on the recommendations of the European antirheumatic league). Modern Rheumatology 2009; (9) :5-9. Russian (Баранов А.А. Рекомендации по ведению больных васкулитами (по материалам рекомендаций Европейской антиревматической лиги). Современная Ревматология 2009; (9):5-9).
3. Karageorgaki ZT, Bertsias GK, Mavragani CP et al. Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol 2009;27(1 Suppl 52):S33-9.
4. Bicakcigil M, Aksu K, Kamali S et al. Takayasu's arteritis in Turkey - clinical and angiographic features of 248 patients. Clin Exp Rheumatol 2009;27(1 Suppl 52):S59-64.
5. Praskurnichy EA. Principles of the pathogenetic therapy of arterial hypertension in systemic vasculitis. Ural Health Survey 1999; 3 (26): 40-3. Russian (Праскурничий Е.А. Принципы патогенетической терапии артериальных гипертензий при системных васкулитах. Уральское Медицинское Обозрение 1999; 3 (26): 40-3)
6. Ohigashi H, Haraguchi G, Konishi M et al. Improved prognosis of Takayasu arteritis over the past decade-comprehensive analysis of 106 patients. Circ J 2012;76(4):1004-11.
7. Lima LT, Christopoulos GB, Braga VM et al. Treatment of mesenteric angina in patients with Takayasu's arteritis. Rev Bras Reumatol 2011;51(2):193-
8. Lightfoot RW, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthr Rheumatol 1990; 27: 1088-93
9. Mills JA, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthr Rheumatol 1990; 27: 1114-20
10. Pagnoux C, Seror R, Henegar C, et al. French Vasculitis Study Group. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010;62(2):616-26.
11. Garzoni L, Vanoni F, Rizzi M et al. Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Rheumatology (Oxford) 2009;48(12):1524-9.
12. Shilkina NP, Stoliarova SA, Yunonin IE, Dryazhenkova IV. Features neuro-humoral regulation of blood pressure in patients with rheumatic diseases. Therapeutic Archives 2009; 81 (6): 37-41. Russian (Шилкина Н. П., Столярова С. А., Юнонин И. Е., Дряженкова И. В. Особенности нейрогуморальной регуляции артериального давления у больных ревматическими заболеваниями. Терапевтический Архив 2009; 81(6): 37-41).
13. Verhave JC, Deegens JK, Beutler JJ.Renal manifestation of Henoch-SchЪnlein purpura in adults. Ned Tijdschr Geneeskd 2011;155:A2933.
14. Eicken S, Gugger M, Marti HP. Glomerulonephritis and vasculitis as causes of arterial hypertension. Ther Umsch 2012;69(5):283-94
15. Savoia C, D'Agostino M, Lauri F, Volpe M. Angiotensin type 2 receptor in hypertensive cardiovascular disease. Curr Opin Nephrol Hypertens 2011;20(2):125-32.
16. Pickering T.G. Renovascular hypertension: etiology and pathophysiology. Semin Nucl Med 1989;19(2):79-88.
17. Welch W.J.The pathophysiology of renin release in renovascular hypertension. Semin Nephrol 2000;20(5): 394-401.
18. Saint-LОzer A, Kostrzewa E, Viallard JF et al. Secondary hyperaldosteronism in a patient with polyarteritis nodosa and renal artery aneurysms. Joint Bone Spine 2011;78(5):524-6.
19. Gogin EE. Hypertensive heart disease yesterday and today. Diagnosis and treatment in the light of fun- damental innovation concepts of the pathogenesis and hemodynamics. Moscow: Eco-Press; 2010. Russian (Гогин Е.Е. Гипертоническая болезнь вчера и сегодня. Диагностика и лечение в свете новаций фундаментальных представлений о патогенезе и гемодинамике. М.: «Эко-Пресс»; 2010).
20. Ghelani SJ, Singh S, Manojkumar R. Endothelial dysfunction in a cohort of North Indian children with Kawasaki disease without overt coronary artery involvement. J Cardiol 2009;53(2):226-31.
21. O'Neil KM, Varma C, Farooq O, Memon A. Glucocorticoid-responsive hypertension in Henoch-Schonlein purpura. Clin Pediatr (Phila) 2010;49(7):702-6.
22. Perk J., De Backer G., Gohlke H., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the Euro- pean Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012;33:1635-701.
23. Drapkina OM, Korneev ON, Chernoff EM. Epicardial fat and non-alcoholic fatty liver disease. Serdtse 2012; 11 (4): 235-43. Russian (Драпкина О.М., Корнеева О.Н., Чернова Е.М. Эпикардиальный жир и неалкогольная жировая болезнь печени. Сердце 2012; 11(4): 235-43)
24. Strizhakov LA, Moses S., E. Semenkova et al. Clinical and pathological variants of heart disease in patients with systemic vasculitis and the possibility of non-invasive diagnostic techniques. Farmateka 2013;
25. (262): 65-71. Russian (Стрижаков Л.А., Моисеев С.В., Семенкова Е.Н. и др. Клинико-патоморфологические варианты поражения сердца у больных с системными васкулитами и возможности методов неинвазивной диагностики. Фарматека 2013; 9 (262): 65-71).
26. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiolody. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-87
27. National guidelines for the diagnosis and treatment of hypertension (fourth revision). SystemicHypertension 2010; (3): 5-26. Russian (Национальные рекомендации по диагностике и лечению артериальной гипертонии (четвертый пересмотр). Системные гипертензии 2010; (3): 5-26).
28. Hafner F, Froehlich H, Gary T et al. Blood pressure measurements in patients with Takayasu arteritis: a work of caution. Ann Thorac Surg 2012;93(4):1299-301.
29. Moiseyev VS, Karpov RS, eds. Blood pressure in research and clinical practice. Moscow: Reafarm; 2004 .Russian (Моисеев В.С., Карпов Р.С., ред. Артериальное давление в исследовательской и клинической практике. М.: Реафарм; 2004).
30. Shilkina NP, Yunonin IE, Stoliarova SA, Dryazhenkova IV. Arterial hypertension in patients with connective tissue diseases and hemorrhagic vasculitis. Therapeutic Archive 2010; 82 (5): 40-5. Russian (Шилкина Н. П., Юнонин И. Е., Столярова С. А., Дряженкова И. В. Артериальная гипертония у больных с системными заболеваниями соединительной ткани и геморрагическим васкулитом. Терапевтический Архив 2010; 82(5): 40-5)
31. Ouali S, Kacem S, Ben Fradj F et al. Takayasu arteritis with coronary aneurysms causing acute myocardial infarction in a young man. Tex Heart Inst J 2011;38(2):183-6.
32. Seibel S, Gaa J, KЯchle C, Frank H. Severe renovascular hypertension in a patient with Takayasu arteritis. Am J Kidney Dis 2010;56(3):595-8.
33. Verhave JC, Deegens JK, Beutler JJ. Renal manifestation of Henoch-SchЪnlein purpura in adults. Ned Tijdschr Geneeskd 2011;155:A2933.
34. Sadurska E, Jawniak R, Majewski M, Czekajska-Chehab E. Takayasu arteritis as a cause of arterial hypertension. Case report and literature review. Eur J Pediatr 2012;171(5):863-9.
35. HorЗkovЗ L, Pudil R, HrncТr Z, Vizd'a J. Cardiomyopathy as one of the less frequent manifestations of Takayasu's arteritis. Acta Medica (Hradec Kralove) 2011;54(4):167-9.
36. HlavЗcovЗ P, VlkovЗ E. Benefit of the surgical treatment of the idiopathic intracranial hypertension-a case report. Cesk Slov Oftalmol 2009;65(5):195-8.
37. Hijazi R, Chandar J, Nwobi O et al. Renal manifestations in toddlers with Takayasu's arteritis and malignant hypertension. Pediatr Nephrol 2009; 24(6):1227-30.
38. Caravita S, Secchi MB, Wu SC et al. Takayasu arteritis with aortic coarctation and multiple stenosis of aortic branches. Recenti Prog Med 2010;101(7-8):293-8.
39. de la Cueva J, PicЧn R, GonzЗlez M, BeltrЗn J. A case of Takayasu's disease presenting as severe secondary hypertension, with angiographic improvement following medical treatment. Rev Esp Cardiol 2010;63(3):365-7.
40. Seibel S, Gaa J, KЯchle C, Frank H. Severe renovascular hypertension in a patient with Takayasu arteritis. Am J Kidney Dis 2010;56(3):595-8.
41. Mukhtyar C, Guilevin L, Cid MC et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheumatol Dis 2009; 3: 310-7
42. Mukhtyar C, Guilevin L, Cid MC et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheumatol Dis 2009; 3: 318-23
43. Ogawa O, Watanabe R, Shimizu H, Masani F. Hypertensive crisis in young woman with Takayasu arteritis. Intern Med 2011;50(18):1963-7.
44. Arend WP, Michel BA, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthr Rheumatol 1990; 27: 1129-34.
45. Watanabe R, Nakaya I, Kudo H et al. Isolated granulomatous renal arteritis: a variant form of giant cell arteritis with few macrophages. Intern Med 2010;49(2):191-4.
46. Hijazi R, Chandar J, Nwobi O et al. Renal manifestations in toddlers with Takayasu's arteritis and malignant hypertension. Pediatr Nephrol 2009; 24(6):1227-30.
47. Deniz A, Yildiz F, Aktas H. et al. Familial Takayasu arteritis in a mother and daughter. A report of two cases. Herz 2013;38(1):93-96.
48. Borazan A, Sevindik OG, Solmaz D et al. A rare cause of renovascular hypertension: Takayasu arteritis with only renal artery involvement. Ren Fail 2009;31(4):327-31.
49. Strizhakov LA Coronary and systemic vasculitis. Diagnosis, differential diagnosis and treatment strategy. Serdtse2010; 9 (1): 60-64. Russian (Стрижаков Л.А. Коронарит и системные васкулиты. Диагноз, дифференциальный диагноз и стратегия лечения. Сердце 2010; 9 (1): 60-64).
50. Małecki R, Zdrojowy K, Adamiec R. Thromboangiitis obliterans in the 21st century-a new face of disease. Atherosclerosis 2009; 206(2):328-34.
51. Graziani L, Morelli L, Parini F et al. Clinical outcome after extended endovascular recanalization in Buerger's disease in 20 consecutive cases. Ann Vasc Surg 2012;26(3):387-95.
52. Nasonov EL. Prospects for the use of statins in rheumatology. Russian Journal of Medicine 2003; 11 (23): 1273-6. Russian (Насонов Е.Л. Перспективы применения статинов в ревматологии. Русский Медицинский Журнал 2003; 11 (23): 1273-6)
53. Plank C, Vasilache I, Dittrich K, DЪtsch J. Early weight gain and outcome in Henoch-SchЪnlein nephritis. Klin Padiatr 2010;222(7):455-9.
54. Masugata H, Senda S, Himoto T et al. Detection of increased arterial stiffness in a patient with early stage of large vessel vasculitis by measuring cardio-ankle vascular index. Tohoku J Exp Med 2009;219(2):101-5.
55. Peters MJ, Symmons PM, McCarey D et al. EULAR evidence-based recommendation for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010;69(2):325-31
56. Mukhtyar C, Brogan P, Luqmani R. Cardiovascular involvement in primary systemic vasculitis. Best Pract Res Clin Rheumatol 2009;23(3):419-28.
57. Lee GY, Jang SY, Ko SM et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int J Cardiol 2012;159(1):14-20.
Review
For citations:
Praskurnichy E.A., Poteshkina N.G. ARTERIAL HYPERTENSION IN SYSTEMIC VASCULITIS: CLINICAL FEATURES AND PRINCIPLES OF PATHOGENETIC THERAPY. PART I. CLINICAL, DIAGNOSTIC AND PATHOGENETIC ASPECTS. Rational Pharmacotherapy in Cardiology. 2013;9(5):557-563. (In Russ.) https://doi.org/10.20996/1819-6446-2013-9-5-557-563
Views:
1482
Email this article 